Clonidine in treatment of hypertension. 1975

F Fragachan, and P Monsalve, and A Tremarias, and L Perez, and A Sanabria

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011187 Posture The position or physical attitude of the body. Postures
D011674 Pulse The rhythmical expansion and contraction of an ARTERY produced by waves of pressure caused by the ejection of BLOOD from the left ventricle of the HEART as it contracts. Pulses
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D005260 Female Females

Related Publications

F Fragachan, and P Monsalve, and A Tremarias, and L Perez, and A Sanabria
January 1971, British medical journal,
F Fragachan, and P Monsalve, and A Tremarias, and L Perez, and A Sanabria
January 1980, Journal of cardiovascular pharmacology,
F Fragachan, and P Monsalve, and A Tremarias, and L Perez, and A Sanabria
September 1976, The Journal of the Association of Physicians of India,
F Fragachan, and P Monsalve, and A Tremarias, and L Perez, and A Sanabria
January 1977, Harefuah,
F Fragachan, and P Monsalve, and A Tremarias, and L Perez, and A Sanabria
February 1971, British medical journal,
F Fragachan, and P Monsalve, and A Tremarias, and L Perez, and A Sanabria
August 1970, British medical journal,
F Fragachan, and P Monsalve, and A Tremarias, and L Perez, and A Sanabria
January 1970, Duodecim; laaketieteellinen aikakauskirja,
F Fragachan, and P Monsalve, and A Tremarias, and L Perez, and A Sanabria
July 1971, The American journal of cardiology,
F Fragachan, and P Monsalve, and A Tremarias, and L Perez, and A Sanabria
April 1973, The Medical journal of Australia,
F Fragachan, and P Monsalve, and A Tremarias, and L Perez, and A Sanabria
April 1978, Minnesota medicine,
Copied contents to your clipboard!